FINWIRES · TerminalLIVE
FINWIRES

日本株は軟調な生産データと中東情勢リスクを受けて下落

By

-- 木曜日の日本株は、中東情勢の緊迫化による経済への圧力の高まりを示す鉱工業生産統計の低迷を受け、下落して取引を終えた。 日経平均株価は前日比1.06%(632.54ポイント)安の59,284.92円で引けた。 政府発表によると、3月の鉱工業生産は前月比0.5%減となり、市場予想の1.1%増を下回った。2月の2.0%減に続き、2ヶ月連続の減少となった。 製造業各社は4月の生産が前月比0.7%減になると予想している。原油価格の上昇がインフレを押し上げ、輸入依存度の高い日本経済を圧迫する中、この低迷傾向は日本銀行にとって大きな課題となっている。 その他の経済指標では、3月の小売売上高は前年同月比1.7%増の14兆3000億円となり、前月の0.1%減から回復した。食品・飲料部門の伸びが燃料販売の減少を相殺した。 企業関連では、山一電子(東証:6941)は、フィリピン子会社がランサムウェア攻撃を受けた後、システムを復旧させ、業務への影響やデータ漏洩はなかったとして、株価が4%上昇した。 グロービング(東証:277A)は、東京証券取引所のグロース市場からプライム市場への上場変更を発表した後、株価が4%下落した。 東邦ホールディングス(東証:8129)は、3Dインベストメント・パートナーズによる大規模な株式取得に対する買収防衛策の発動について株主総会での承認を求める方針を発表した後、株価が3%上昇した。

Related Articles

Equities

Berenberg Adjusts Estimates for Galp Energia After 'Solid' Q1 Results; Hold Rating Maintained

Berenberg updated its earnings forecasts for Galp Energia (GALP.LS) after the Portuguese energy company reported its first-quarter results."Galp reported a solid set of results for Q126 on 27 April from an operational point of view, and beat consensus EBITDA expectations, although this was offset by some cash flow adjustments in the period. Delivery of the important Bacalhau project (Brazil) appears to be ahead of expectations, and, after a strong Q1 in the refining business, Galp is moving towards confirming the terms of its downstream merger with Moeve. In the earnings call, the company indicated that its 2026 guidance is now likely out of date given the macro backdrop, and that it may update its FY26 outlook in the Q2 results. We leave our Hold rating and EUR20 price target unchanged," the research firm said Wednesday.Against this backdrop, the research firm increased its 2026 EBITDA assumption by 3%, while cutting its cash flow from operations and free cash flow estimates by 4% and 3%, respectively, to account for a recent 320 million-euro renewable acquisition and other liquidity adjustments.Meanwhile, analysts maintained their share repurchase projection for 2026 at 250 million euros, while boosting their 2027 forecast to 455 million euros, which is 10% above consensus. Berenberg's EPS estimates for 2026 through 2028 were also revised upwards.

$GALP.LS
Asia

Henlius Biotech Doses First Patient in Lung Cancer Drug Trial in China

Shanghai Henlius Biotech (HKG:2696) dosed the first patient in a phase 1 clinical study of HLX3901 in mainland China, according to a Thursday Hong Kong bourse filing.The drug is being tested for the treatment of patients with advanced small-cell lung cancer or neuroendocrine carcinoma.

$HKG:2696
Equities

BP Confirms Preliminary Offshore Exploration Agreement With Venezuela

BP (BP.L) entered into a memorandum of understanding with the Bolivarian Republic of Venezuela to establish "potential areas for co‑operation in material offshore gas and future exploration," according to a statement sent toon Thursday.Venezuela's Acting President Delcy Rodríguez announced in a Wednesday signing event its offshore natural gas exploration deal with the British oil major, which covers the Deltana Platform, an oil and natural gas reservoir in the nation's eastern waters, according to a same-day report from Bloomberg News.BP Executive Vice President William Lin also said the company plans to launch a permanent regional office in Caracas, Venezuela.

$BP.L